Loyens & Loeff is highly sought-after for its expertise across high-stakes and large-scale litigation and arbitration proceedings. Hakim Boularbah represents major multinational clients in regulated sectors – including banking, life sciences, energy, telecommunications, and chemicals – on landmark corporate, commercial, and mass claims litigation. Boularbah also acts in critical ICC and UNCITRAL arbitration proceedings. Olivier van der Haegen boasts a leading arbitration practice, particularly in the energy and chemicals segments, acting on CEPANI and ICC proceedings concerning commercial and construction contracts. Van der Haegen elsewhere handles real estate litigation cases. Maria-Clara Van den Bossche left the firm.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Excellent engagement of the teams in this litigation. Excellent advice in terms of strategy and the connection with the other party.’
‘Hakim Boularbah is extremely experienced and a real pleasure to work with.'

Key clients

Eoliennes en Mer de Dunkerque, subsidiary of the French EDF (Electricité de France)
Blasket
Pfizer
3M Company
Ligue des Droits Humains
MEAG (German Real Estate Developer)
BNP Paribas
Nyrstar
ByteDance (TikTok)
AstraZeneca
Porsche AG
Eurelec
Meta Platforms
Klépierre
John Cockerill
Credendo

Work highlights

Advised BNP Paribas in defending against an €8.5bn collective action brought by Fortis minority shareholders over the 2008 takeove.

Advised Pfizer in its dispute with the EU and several Member States over payment and delivery obligations under Covid-19 vaccine purchase agreements, including representing the company in litigation against Hungary, Poland, and Romania.

Advised Eoliennes en Mer de Dunkerque in litigation initiated by the Port of Ostend seeking to block the construction of a French offshore windfarm near Dunkerque.

Lawyers

Hall of Fame

The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.